Skip to main content
Kumar Abhishek, MD, Oncology, Mechanicsville, VA

Kumar Abhishek MD


Forward thoughts

Join to View Full Profile
  • 8266 Atlee RdSuite 225Mechanicsville, VA 23116

  • Phone+1 804-764-7220

  • Fax+1 804-764-6212

Dr. Abhishek is on Doximity

As a Doximity member you'll join over two million verified healthcare professionals in a private, secure network.

  • Gain access to free telehealth tools, such as our “call shielding” and one-way patient texting.
  • Connect with colleagues in the same hospital or clinic.
  • Read the latest clinical news, personalized to your specialty.

Education & Training

  • SSM Health/Saint Louis University School of Medicine
    SSM Health/Saint Louis University School of MedicineFellowship, Hematology and Medical Oncology, 2009 - 2012
  • Carilion Clinic-Virginia Tech Carilion School of Medicine
    Carilion Clinic-Virginia Tech Carilion School of MedicineResidency, Internal Medicine, 2004 - 2007
  • Delhi University College of Medical Sciences
    Delhi University College of Medical SciencesClass of 2000
  • University of Iowa Hospitals and Clinics
    University of Iowa Hospitals and ClinicsResidency, Internal Medicine

Certifications & Licensure

  • VA State Medical License
    VA State Medical License 2004 - 2026
  • MO State Medical License
    MO State Medical License 2009 - 2012
  • PA State Medical License
    PA State Medical License 2008 - 2010
  • Internal Medicine
    American Board of Internal Medicine Internal Medicine
  • Hematology
    American Board of Internal Medicine Hematology
  • Medical Oncology
    American Board of Internal Medicine Medical Oncology

Awards, Honors, & Recognition

  • CMS Meaningful Use Stage 1 Certification EpicCare Ambulatory EMR, Epic Systems Corporation, 2012-2013

Publications & Presentations

PubMed

Press Mentions

  • India Today Reporter Kumar Abhishek Gets Second Dose of Bharat Biotech's Covaxin as Part of Phase 3 Trials
    India Today Reporter Kumar Abhishek Gets Second Dose of Bharat Biotech's Covaxin as Part of Phase 3 TrialsJanuary 9th, 2021

Viewing the full profile is available to verified healthcare professionals only.

Find your profile and take control of your online presence: